Table 1.
Demographics of Patients Screened
| Characteristic | Total | Positive MC (< 4) | Negative MC (4–5) | ||||
|---|---|---|---|---|---|---|---|
| Total | PC | Neuro | Total | PC | Neuro | ||
| N (%) | 787 | 231 (29.4) | 74 (22.4) | 157 (34.4) | 556 (70.6) | 257 (77.6) | 299 (65.6) |
| Age (SD) | 77.2 (6.2) | 79.6 (6.4) | 78.2 (6.9) | 80.2 (6.1) | 76.2 (5.8) | 75.3 (6.0) | 77.0 (5.4) |
| Male | 316 (40.2) | 100 (43.3) | 26 (35.1) | 74 (47.1) | 216 (38.9) | 96 (37.4) | 120 (40.1) |
| White race1 | 751 (95.4) | 216 (93.5) | 71 (96.0) | 145 (92.4) | 535 (96.2) | 251 (97.7) | 284 (95.0) |
| Hispanic | 10 (1.3) | 4 (1.7) | 0 (0) | 4 (2.6) | 6 (1.1) | 1 (0.4) | 5 (1.7) |
Values listed as n (%), unless indicated otherwise
1Other races include Black or African American (n = 14), Asian or Pacific Islander (n = 3), American Indian or Alaskan Native (n = 1), some other race (n = 4), and NA/unknown (n = 14)